ReviewInfection2022

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection.

Mostafa Akbarzadeh-Khiavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.